CLASS II Device recall · Reported 19 Feb 2020 · FDA Enforcement Report

G6 CGM App for iOS recalled by Dexcom

Dexcom is recalling G6 CGM App for iOS, distributed nationwide in the US. The recall was initiated on 19 Nov 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSoftware Number: SW11677 Software Version: 1.4.0 up to corrected Version 1.4.4 GUDID Registered GTIN: 00386270000804
Quantity recalled237888 users registered.

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1104-2020
FDA event ID
84436
Recalling firm
Dexcom, San Diego, CA
Classification
Class II
Status
Terminated
Recall initiated
19 Nov 2019
FDA classified
7 Feb 2020
Reported
19 Feb 2020
Type
Voluntary: Firm initiated
Customers notified by
Other
Reason category
Device Malfunction

Timeline

19 Nov 2019Recall initiated by company
7 Feb 2020Classified by FDA+80 days
19 Feb 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

It was reported that the user's low alarm feature on the iOS application were not properly alerting users when the user has enabled the Alert Schedule feature more than 30 days after installing the iOS application.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Brand Name: Dexcom G6 CGM App for iOS Software Number: SW11677 Software Version: Version 1.4.0 up to corrected Version 1.4.4 GUDID Registered GTIN: 00386270000804

Where it was distributed

US Nation-wide OUS: Austria; Belgium; Canada; Czechia; Denmark; Finland; Germany; Great Britain; Hong Kong; Ireland; Italy; Luxembourg; Netherlands; Norway; South Africa; Spain; Sweden, and Switzerland.

Nationwide

Questions about this recall

Why was it recalled?

It was reported that the user's low alarm feature on the iOS application were not properly alerting users when the user has enabled the Alert Schedule feature more than 30 days after installing the iOS application.

Which lots are affected?

Software Number: SW11677 Software Version: 1.4.0 up to corrected Version 1.4.4 GUDID Registered GTIN: 00386270000804

Where was it sold?

US Nation-wide OUS: Austria; Belgium; Canada; Czechia; Denmark; Finland; Germany; Great Britain; Hong Kong; Ireland; Italy; Luxembourg; Netherlands; Norway; South Africa; Spain; Sweden, and Switzerland.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Dexcom

All 29

Other Insulin Pumps & Glucose Monitors recalls

All 465